Table 3.
Day 28b | Day 63c | |||
---|---|---|---|---|
Immunization | ||||
IgA | IgG | IgA | IgG | |
NB-Ctb (IN/IP) | 0.4 ×/÷ 4.4 | 0 | 0.5 ×/÷ 3.0 | 7.1 ×/÷ 3.4 |
NB-L2-Ctb (IN/IP) | <0.1d | 0 | 0.6 ×/÷ 5.3 | 10.8 ×/÷ 1.7 |
NB-L2-Ctb (s.c./ IP) | 0 | 5.8 ×/÷ 3.5e | 0.7 ×/÷ 3.8f | 12.8 ×/÷ 1.3f |
Data are expressed as the geometric mean of the percentage (specific antibody/total antibody) ×/÷ standard deviation.
Day 28 is 7 days after final IN prime.
Day 63 is 7 days after final boost.
Only two mice had detectable TbpB-specific antibodies.
Only three mice had detectable TbpB-specific antibodies.
n = 4.